Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Vigene Biosciences
Rockville, Maryland, United States
- Ownership
- Private
- Development stage
- Other
01
Overview
Vigene Biosciences manufactures research-grade and cGMP-grade viral vectors for gene therapy and biomedical research, supporting both preclinical and clinical programs for third-party developers, and is recognized for enabling innovative studies but does not itself run drug development trials[1][2][3][6].
- Modalities
- Gene therapyViral vector (Adeno-associated virus, Lentivirus, Adenovirus, Retrovirus)Plasmid
- Industry
- Contract Manufacturing Organization
02
Partnerships
Janelia Research Campus (AAV biosensors)The Michael J Fox Foundation (AAV alpha-synuclein vectors for Parkinson’s disease)Altimmune (manufacturing for AdCOVIDTM, COVID-19 vaccine candidate)
Beyond the preview
Go deeper on Vigene Biosciences.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Vigene Biosciences.